PAF (C16)

ligand for PAF receptors CAS# 74389-68-7

PAF (C16)

Catalog No. BCC7522----Order now to get a substantial discount!

Product Name & Size Price Stock
PAF (C16): 5mg $368 In Stock
PAF (C16): 10mg Please Inquire In Stock
PAF (C16): 20mg Please Inquire Please Inquire
PAF (C16): 50mg Please Inquire Please Inquire
PAF (C16): 100mg Please Inquire Please Inquire
PAF (C16): 200mg Please Inquire Please Inquire
PAF (C16): 500mg Please Inquire Please Inquire
PAF (C16): 1000mg Please Inquire Please Inquire
Related Products

Quality Control of PAF (C16)

Number of papers citing our products

Chemical structure

PAF (C16)

3D structure

Chemical Properties of PAF (C16)

Cas No. 74389-68-7 SDF Download SDF
PubChem ID 108156 Appearance Powder
Formula C26H54NO7P M.Wt 523.68
Type of Compound N/A Storage Desiccate at -20°C
Synonyms Platelet-activating factor
Solubility Soluble to 100 mM in water and to 100 mM in ethanol
Chemical Name [(2R)-2-acetyloxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
SMILES CCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C
Standard InChIKey HVAUUPRFYPCOCA-AREMUKBSSA-N
Standard InChI InChI=1S/C26H54NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-31-23-26(34-25(2)28)24-33-35(29,30)32-22-20-27(3,4)5/h26H,6-24H2,1-5H3/t26-/m1/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of PAF (C16)

DescriptionEndogenous platelet-activating factor (PAF) and ligand for PAF receptors. Produced by inflammatory cells and a potent chemoattractant for polymorphonuclear neutrophils. Induces increased vascular permeability.

PAF (C16) Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

PAF (C16) Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of PAF (C16)

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.9096 mL 9.5478 mL 19.0956 mL 38.1913 mL 47.7391 mL
5 mM 0.3819 mL 1.9096 mL 3.8191 mL 7.6383 mL 9.5478 mL
10 mM 0.191 mL 0.9548 mL 1.9096 mL 3.8191 mL 4.7739 mL
50 mM 0.0382 mL 0.191 mL 0.3819 mL 0.7638 mL 0.9548 mL
100 mM 0.0191 mL 0.0955 mL 0.191 mL 0.3819 mL 0.4774 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on PAF (C16)

PAF (C16) is an endogenous platelet-activating factor (PAF) and ligand for PAF receptors.
The platelet-activating factor receptor is a G-protein coupled receptor which binds platelet-activating factor.
PAF is produced by inflammatory cells and polymorphonuclear neutrophils. It induces increased vascular permeability. To examine the loss of selective endothelial permeability, the extravasative effect of PAF was assessed by monitoring the plasma loss of 125I-albumin (6.7 nm), 125I-low density lipoproteins (22.0 nm) and 125I-very low density lipoproteins (62.1 nm). There was no selective plasma retention of the labeled plasma tracers, which suggest that PAF-induced extravasation is dose-dependent, with increases in vascular permeability [1].
Given into the renal arterial circulation of male Wistar rats, PAF (C16) increased in renal blood flow (6-15%) in a dose-dependent way. The PAF-induced systemic hypotension and renal vasodilation are independent of renal innervation and are PAF-receptor mediated [2].
References:
[1]. Handley DA, Arbeeny CM, Lee ML, et al. Effect of platelet activating factor on endothelial permeability to plasma macromolecules. Immunopharmacology, 1984, 8(3-4): 137-142.
[2]. Handa RK, Strandhoy JW, Buckalew VM Jr. Platelet-activating factor is a renal vasodilator in the anesthetized rat. Am J Physiol, 1990, 258(6 Pt 2): F1504-1509.

Featured Products
New Products
  • Symlandine

    Catalog No.:BCN1974
    CAS No.:74410-74-5
  • Sauvagine

    Catalog No.:BCC5792
    CAS No.:74434-59-6
  • Potassium Chloride

    Catalog No.:BCC7581
    CAS No.:7447-40-7
  • Casegravol

    Catalog No.:BCN4591
    CAS No.:74474-76-3
  • Alprostadil

    Catalog No.:BCC4963
    CAS No.:745-65-3
  • MMAF

    Catalog No.:BCC5144
    CAS No.:745017-94-1
  • Ivachtin

    Catalog No.:BCC2357
    CAS No.:745046-84-8
  • UBP 296

    Catalog No.:BCC7255
    CAS No.:745055-86-1
  • UBP 302

    Catalog No.:BCC7256
    CAS No.:745055-91-8
  • Cristacarpin

    Catalog No.:BCN3935
    CAS No.:74515-47-2
  • Isomedicarpin

    Catalog No.:BCN4297
    CAS No.:74560-05-7
  • D-64131

    Catalog No.:BCC1510
    CAS No.:74588-78-6
 

References on PAF (C16)

Vasorelaxant effect of C16-PAF and C18-PAF on renal blood flow and systemic blood pressure in the anesthetized rat.[Pubmed:1875784]

Life Sci. 1991;49(10):747-52.

The renal vasoactive and systemic hypotensive effects of platelet activating factor (C16:0-PAF and C18:1-PAF) were examined in anesthetized male Wistar rats. Bolus injections of C16-PAF (0.5-25 ng/kg) and C18-PAF (2.5-200 ng/kg) into the arterial circulation of the kidney produced increases in renal blood flow (6-15%) before causing dose-dependent systemic hypotension (2-64 mmHg). The dose-response curves for renal blood flow and systemic blood pressure generated by intrarenal C18-PAF administration were approximately 7 fold to the right of the dose-response curves generated by C16-DPAF. Intrarenal injections of vehicle or the biologically inactive enantiomer C16-DPAF (25-200 ng/kg) did not affect renal blood flow or systemic blood pressure. These results suggest that C16:0-PAF is a more potent renal vasodilator and hypotensive lipid than C18:1-PAF.

Actions of platelet activating factor (PAF) homologues and their combinations on neutrophil chemokinesis and cutaneous inflammatory responses in man.[Pubmed:3385217]

J Invest Dermatol. 1988 Jul;91(1):82-5.

The inflammatory actions of synthetic C16:0 and C18:0 platelet activating factor (PAF) homologues, both alone and in combination, have been compared in an in vitro human neutrophil chemokinesis assay and by intradermal injection in human skin. In the chemokinesis assay, the maximum distance moved by neutrophils in the presence of C18:0 PAF was significantly greater than that seen with the C16:0 compound. A mixture of C16:0 and C18:0 PAFs in a ratio of 1:9 appeared to be more active than in a ratio of 3:1. Intradermal injection of the C16:0 and C18:0 PAF homologues induced dose-dependent increases in weal volume and flare area responses which were not significantly different. Combination of these phospholipids in a ratio of 3:1 or 1:9 of C16:0:C18:0 did not significantly alter the dose response curves. Thus, changes in the chain length of the alkyl substituent of synthetic PAF homologues and combination of these homologues, in ratios found in vivo or formed by leukocytes in vitro, did not alter the cutaneous inflammatory responses to PAF in man. The C18:0 homologue was, however, more active as a human neutrophil chemoattractant in vitro.

Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187.[Pubmed:3917470]

J Immunol. 1985 Feb;134(2):1090-3.

Two species of platelet-activating factor (PAF), 1-hexadecyl- and 1-octadecyl-2-acetyl-sn-glycero-3-phosphocholine (C16 = 0 AGEPC and C18 = 0 AGEPC) were detected in ionophore A23187-stimulated human neutrophils. The amount of AGEPC in 1 x 10(7) neutrophil cells was 80 +/- 26 pmol (mean +/- standard error) with a range of 14 to 223 pmol (n = 8), and it consisted of 80% of the C16 = 0 species and 20% of the C18 = 0 species. Most of the AGEPC derived from ionophore-treated neutrophils remained cell associated rather than being secreted into the medium, even when the medium contained ample albumin protein, which can trap AGEPC. These results were obtained by a technique of gas chromatography-mass spectrometry coupled with selected ion monitoring.

Description

Endogenous platelet-activating factor (PAF)

Keywords:

PAF (C16),74389-68-7,Platelet-activating factor,Natural Products,PAF Receptors, buy PAF (C16) , PAF (C16) supplier , purchase PAF (C16) , PAF (C16) cost , PAF (C16) manufacturer , order PAF (C16) , high purity PAF (C16)

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: